Hope in the fight against cancer: They build proteins that are not known to nature
Basel-based biotech startup has big ideas for the future: it aims to take protein engineering into a new era
15-Jun-2021 -
Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich.
Jeffrey Bode’s long, bold journey began over an after-work beer in Tokyo. A ...
artificial proteins
cancer
cancer immunotherapies
+3